OUR STORY

Seurat Therapeutics sprung from the University of Chicago and is currently based at the Polsky Exchange. We are a team passionate about innovating migraine care and accelerating the translation of scientific discoveries into life-changing medicine. 

OUR VISION

In the U.S., 1 out of 10 people suffer from migraines. Due to the lack of medicine that truly treat the cause of these migraines, patients are often left helpless and have to resort to bed rest for hours to days. Our mission is to give these people their lives back.

OUR APPROACH

The science behind Seurat Therapeutics is based on years of research from the University of Chicago medical center. Our treatment philosophy stems from a belief that novel neurotherapeutics based on EE can improve brain health.

MARTIN SANDERS, MD

Co-Founder

Chairman

YUAN ZHANG, PHD, MS

Co-Founder

CEO and President

RICHARD KRAIG, MD, PHD

Co-Founder

Chief Scientific Officer

SHARON LEW, MS

Chief Financial Officer